Articles tagged with Estrogen
A new study by The Endocrine Society reveals that chemicals remaining in Boulder Creek after wastewater treatment change the gender of fish. Native male fish were found to be feminized, with intersex individuals also present downstream of the wastewater treatment plant.
Researchers found that smoke triggers rapid changes in gene expression in the lungs of female mice, increasing expression of genes involved in estrogen metabolism. These findings suggest that estrogen metabolism may contribute to lung cancer in non-smoking women.
Researchers at Yale University found that prenatal exposure to BPA and DES can increase an offspring's risk of breast cancer. The chemicals, known as endocrine disruptors, alter gene expression in the breast throughout life, leading to a higher risk of breast cancer in adults.
Estrogen has been found to decrease airway constriction and increase bronchodilation in human airway smooth muscle cells, particularly when combined with beta-agonists. This suggests that estrogen may be beneficial for women with asthma, and further research is needed to explore its potential as a treatment option.
SE5-OH containing natural S-equol significantly reduced frequency of hot flushes in postmenopausal women. The compound had no effect on reproductive hormones E2 and FSH, suggesting its potential as a critical component in reducing menopausal symptoms.
A new study suggests that high estrogen levels in men may increase their risk of developing prostate cancer. However, the researchers also found that certain estrogen metabolites may offer a protective benefit against prostate cancer development.
Researchers discover how breast cancer cells become resistant to hormone-dependent treatments like tamoxifen by activating a specific biochemical cascade. The study reveals the permanent stimulation of cyclic AMP in cells refractory to therapy, providing key answers to understanding resistance.
A study found Raloxifene improves psychosis symptoms and enhances memory in postmenopausal women with schizophrenia. The therapy may revolutionize treatment options for women suffering from the condition.
Researchers found that fulvestrant's anti-cancer effects are enhanced when cells express high levels of cytokeratins CK8 and CK18, structural proteins involved in estrogen regulation. The study suggests that testing for these proteins could help doctors decide whether fulvestrant should be prescribed to patients.
Researchers at Yale School of Medicine have discovered that exposure to Bisphenol A (BPA) during pregnancy causes permanent abnormalities in the uterus of offspring. The study found that BPA exposure permanently alters gene expression and DNA modification in the uterus, leading to hyper-responsiveness to estrogens.
A new study published in the Journal of Clinical Oncology found that women taking estrogen plus progestin hormone replacement therapy for 10 or more years have a 50% increased risk of developing lung cancer compared to non-users. The study also suggests that duration of use is associated with an advanced stage of cancer at diagnosis.
Researchers found that postmenopausal women using HRT had a higher risk of cataract removal compared to those who never used the therapy. Additionally, smoking was linked to an increased risk of uveitis, a serious eye disease causing inflammation in the middle layer of the eye.
BPA exposure during pregnancy leads to epigenetic changes causing permanent reproductive issues in females, including fertility problems and hormone-related cancers. The study also suggests that early exposure can genetically program the uterus to be hyper-responsive to estrogen.
Researchers at the University of Texas Medical Branch found that offspring of female mice exposed to BPA developed significant signs of asthma. The study suggests a link between maternal BPA exposure and childhood asthma, highlighting the need for further human epidemiological studies.
A Tel Aviv University study found that restoring normal estrogen levels can alleviate schizophrenia-like behavior in female rats. The researchers also discovered that estrogen increases the effectiveness of anti-psychotic drugs, providing potential hope for treating psychosis in women vulnerable to schizophrenia.
Researchers found that estrogen stimulates parts of the brain dedicated to learning and memory through a protein called calpain. This discovery may lead to better drugs against Alzheimer's and other neurodegenerative diseases by targeting calpain directly.
Researchers at Johns Hopkins found that vitamin D deficiency amplifies the negative effects of low estrogen levels on heart health and bones. Men with low vitamin D and estrogen levels were more likely to develop osteopenia and cardiovascular diseases.
Researchers have identified a molecular mechanism underlying the harmful effects of DES on male testis development and function. Neonatal exposure to DES leads to reduced fertility in mice, with NR0B2 deficiency protecting against these effects.
A combination of estrogen and a selective estrogen receptor modulator (SERM) may relieve menopause symptoms and lower breast cancer risk without the progestin side effects. Researchers treated breast and endometrial cell lines with the hormone mix, finding that it blocked cell growth and prevented proliferation.
A study at UCSF has identified networks of nerve cells controlled by estrogen that influence male territorial behavior, challenging the view of single gender-related behaviors.
A new study in mice reveals that early estrogen exposure 'masculinizes' the brain circuitry, leading to aggressive and territorial behaviors typically observed in males. The researchers found that female mice exposed to estrogen as pups exhibit similar behaviors, suggesting a critical role for estrogen in shaping masculine behavior.
New research from Purdue University raises concerns about estrogen supplements claiming to improve bone health in postmenopausal women. While some plant-derived isoflavones show modest effects, many supplements lack efficacy or are less effective than current treatments for osteoporosis.
A recent study found that low-dose estrogen treatment can stop disease progression in patients with metastatic breast cancer, with 87% of those without PET flare reactions showing no response. The treatment was also well-tolerated, with fewer severe side effects compared to high doses.
Researchers found high concentrations of phytoestrogens, hormone-mimicking compounds, in the wastewater discharged from eight industrial sites. Phytoestrogens can be removed through standard treatment, but levels may still harm fish at certain thresholds.
Researchers discovered that uterine stromal cells increase estrogen production through the enzyme aromatase, supporting decidualization and blood vessel growth. Progesterone supplementation is necessary for successful pregnancy, highlighting the benefits of local estrogen production.
Researchers found that estrogen suppresses p53 after stroke, preventing cell death and reducing damage. The study used female rats treated with estrogen versus placebo to induce global cerebral ischemia, a common type of ischemic stroke.
Research highlights the gender disparities in stroke risks, with males outnumbering females by two to one, while women's outcomes worsen with age. Women also face disadvantages in stroke treatment, including lower response rates to tissue plasminogen activator.
A recent study has identified a 'feed-forward' pathway that links estrogen receptors in the uterus to increased local estrogen levels and promotes cell growth. This pathway may be targeted in drug therapies for endometriosis and uterine cancer.
A new study found that estrogen action through GPR30 promotes breast tumor cell survival, rather than growth, and activates integrin α5β1 to create a provisional extracellular matrix. This suggests that targeting GPR30 may be an important step in controlling ER-positive breast cancer.
Researchers from the University of Chicago discovered a 'yin-yang' effect between estrogen and retinoic acid on gene expression in breast cancer cells. This balanced control can lead to new ways of preventing and treating breast cancer, including more precise diagnoses and novel anti-cancer drugs.
Research suggests that estrogens acting through their receptors affect the dopamine transporter, which may explain trends in timing of women's susceptibility to these diseases. Estrogen levels vary significantly at different life stages, and women are more likely to experience neurological disease onset or exacerbation during these times.
Exposure to low-dose BPA and estrogen increases arrhythmias in female rats and mice, a new study found. The results suggest a possible risk for female heart health due to increased levels of estrogens in the body and exposure to environmental estrogen BPA.
Bisphenol A (BPA) exposure may be associated with abnormal activity in female rat and mouse hearts, potentially leading to improper heartbeat control. Researchers found estrogen receptors play a key role in this effect, which could have significant implications for women's heart health.
Research by USGS scientists links estrogen exposure to reduced immune response in largemouth bass, potentially making them more vulnerable to diseases. The study reveals that estrogen blocks production of hepcidin, a hormone that regulates iron and has antimicrobial properties.
A study published in JAMA found that men with systolic chronic heart failure who have low or high levels of estradiol have an increased risk of death compared to those with moderate levels. The study, conducted on 501 men, showed that both low and high concentrations of circulating estradiol are significant predictors of a poor prognosis.
A recent study found that women have a more powerful innate immune system than men due to the presence of estrogen. Estrogen blocks an enzyme called Caspase-12, which prevents the inflammatory process, making women more resistant to infection.
A new study by Penn State professor Donna Korzick explores the link between estrogen deficiency and increased risk of heart disease in women. Researchers hope to identify proteins that respond to low-estrogen environments, which could lead to new treatments for heart disease.
A large observational study found that combined oral contraceptives are associated with an increased risk of systemic lupus erythematosus (SLE), particularly among women who started using them recently. The study suggests a possible dose-response effect of estrogen on SLE onset.
A new study published in Menopause: The Journal of the North American Menopause Society found that transdermal estrogen delivery may not increase the risk of blood clots in postmenopausal women, unlike oral delivery. The study suggests that transdermal HT delivery may be a safer alternative for some women.
A study by Wagner and Oehlmann analyzed mineral waters for estrogenic chemicals, detecting contamination in 60% of samples. Plastic bottle water showed higher levels than glass-bottled water, with more embryos developing in New Zealand mud snails exposed to plastic bottles.
A study published by the American Academy of Neurology found that people with osteoporosis are three times more likely to experience vertigo than those without. Researchers discovered a strong link between low bone density and an increased risk of inner ear disorders, which can cause dizziness.
Researchers found that estrogen activates genes encoding nitric oxide synthases, leading to enhanced lung function and reduced ventilation support needs. Estrogen also prevented low blood pressure and closed the ductus arteriosus, a shunt that connects the pulmonary artery to the aorta.
A study from the Women's Health Initiative found that postmenopausal women who stopped taking combined estrogen plus progestin experienced a marked decline in breast cancer risk. The researchers also discovered that continued use of the hormone therapy after five years doubles subsequent breast cancer risk each year.
Primary ovarian insufficiency is a menopause-like condition affecting girls and young women, characterized by loss of menstrual periods, infertility, and hot flashes. A comprehensive plan provides recommendations for diagnosis and treatment, including hormone replacement therapy and counseling.
A new study confirms that estrogen and progesterone increase the risk of breast cancer more than estrogen alone. The study suggests a two-year safe period for hormone replacement therapy.
Key epigenetic abnormalities in endometriosis have been identified, including the presence of aromatase, which produces excessive estrogen in affected tissue. Aromatase inhibitors are now being tested for treatment options.
Dr. Debashis Ghosh's groundbreaking work has determined the three-dimensional structure of aromatase, a key enzyme in estrogen production. This breakthrough opens doors to customized, comprehensive medical treatment for breast cancer patients.
A diet rich in fruits, vegetables, and fiber has been shown to reduce the risk of recurrence in early-stage breast cancer survivors who do not experience hot flashes. This subgroup of patients typically faces higher recurrence rates and lower survival rates compared to those with hot flashes.
A secondary analysis of a large clinical trial found that a diet high in fruits, vegetables, and fiber reduces the risk of breast cancer recurrence by approximately 31 percent in women without hot flashes. Women with estrogen receptor-positive cancers often receive hormone therapy to combat circulating estrogen levels.
A study found that estrogen therapy can stop the growth of tumors or cause them to shrink in about a third of women with metastatic breast cancer that has developed resistance to standard estrogen-lowering therapy. The high-dose regimen had significant side effects, while the low-dose regimen was well tolerated.
Research articles explore impact of endocrine-disrupting chemicals on aquatic vertebrates and humans. Studies reveal mechanisms behind reproductive abnormalities and ecological risks associated with environmental contaminants.
Researchers discovered that past oral contraceptive use can reduce estrogen levels for years after treatment is stopped, potentially leading to a reduced risk of ovarian and uterine cancers. The study used cynomolgus monkeys and found significant reductions in estrogen metabolites three years after surgical menopause.
A study found that genistein, a soy-based dietary supplement, can negate the effectiveness of aromatase inhibitors used to treat post-menopausal breast cancer. The researchers observed a dose-dependent reduction in treatment efficacy, leading to tumor growth.
Researchers found that hormone levels alter the brain's response to social cues, affecting preferences for male voices and behavior. The study suggests a possible neural basis for changes in human social decision-making across the menstrual cycle.
A study by Université de Montréal researchers found that Montreal's water treatment plants dump up to 90 times the critical amount of estrogen products into the river. The presence of these hormones can disrupt the endocrine system of fish and decrease their fertility, threatening aquatic ecosystems.
A new study led by the University of Leicester found that men's sex hormones, particularly estradiol and estrone, are associated with increased cardiovascular risk factors such as high total cholesterol and LDL-cholesterol. This suggests that natural endogenous estrogens may play a role in increasing heart disease risk in men.
Researchers investigated estrogen's action in the brain, finding that it protects neurons and enables learning and memory throughout life. Estrogen receptors are present in both men and women, and a protein called PELP-1 enables rapid hormone action.
Scientists are studying zebra finches, a type of songbird, to understand how hormones like estrogen impact brain function and behavior. The research aims to uncover the role of synaptically produced estrogen in learning, memory, and neuroprotection.
A randomized, double-blind study involving 102 women with schizophrenia found that estrogen estradiol improved psychotic symptoms more effectively than antipsychotic medications alone. No significant difference was observed in negative symptoms, suggesting potential for longer-term treatment or alternative approaches.
Researchers at University of Illinois found that chronic exposure to estradiol decreases working memory and response inhibition in rats. This impairment is linked to altered brain activity in the prefrontal cortex, a region crucial for planning and decision-making.